Picture of Supernus Pharmaceuticals logo

SUPN — Supernus Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Brief: Supernus Announces Second Quarter 2022 Financial Results

Aug 4 (Reuters) - Supernus Pharmaceuticals Inc  SUPN.O :
    * SUPERNUS ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS
    * Q2 2022 TOTAL REVENUES OF $170.1 MILLION, A 20% INCREASE COMPARED TO Q2
2021
    * QTRLY EARNINGS PER SHARE $0.14
    * SEES 2022 TOTAL REVENUES IN THE RANGE OF $640 MILLION - $680 MILLION
    * Q2 EARNINGS PER SHARE VIEW $0.29 -- REFINITIV IBES DATA
    * Q2 REVENUE VIEW $164.2 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX5LY5V1 
Further company coverage:  SUPN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Supernus Pharmaceuticals

See all news